vTv Therapeutics Inc. logo

vTv Therapeutics Inc.

VTVT | NASDAQ
Chart Builder DCF Calculator
$31.61
+$0.31 (+0.99%)
Sep 22, 2026, 12:20 PM ET · Market open
TTM
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
36.84M 36.84M n/a 17K 17K 17K 1.02M 1M 1M 1M n/a 9K 9K 18K 2.02M 2.02M 5.02M 5.02M 4.01M 10.4M 7.4M 7.39M
Cost of Revenue
1K 1K n/a 22K 22K 22K 22K n/a n/a n/a n/a n/a n/a 2.21M 5.34M 10.04M 12.42M 12.65M 12.62M 10.46M 9.84M 14.12M
Gross Profit
36.84M 36.84M n/a -5K -5K -5K 995K 1M 1M 1M n/a 9K 9K -2.19M -3.32M -8.02M -7.4M -7.64M -8.62M -61K -2.44M -6.73M
Operating Income
-9.25M -3.04M -32.81M -29.82M -25.62M -25.06M -24.18M -24M -22.86M -23.7M -25.5M -27.14M -27.46M -23.49M -22.54M -27.31M -23.22M -23.86M -21.66M -8.72M -9.95M -9.49M
Interest Income
2.91M 2.38M 1.87M 1.43M 1.54M 1.82M 1.57M 1.22M 851K 451K 472K 536K 555K 452K 352K 200K 50K n/a 1K 1K 1K 1K
Pretax Income
-6.4M -729K -31.08M -28.38M -23.87M -22.9M -22.61M -22.61M -25.31M -26.11M -25.97M -27.62M -24.54M -21.42M -24.87M -28.27M -24.16M -20.91M -17.62M -6.53M -7.41M -11.56M
Net Income
-4.76M 2.25M -26.97M -23.47M -19.56M -18.69M -18.46M -18.31M -20.18M -20.62M -20.25M -21.52M -19.12M -16.66M -19.16M -21.47M -18.3M -15.75M -12.99M -4.81M -5.26M -8.02M
Selling & General & Admin
17.41M 15.87M 14.95M 13.65M 13.25M 13.35M 13.65M 13.55M 12.81M 12.4M 11.91M 11.73M 11.82M 10.34M 12.2M 14.63M 14.22M 14.63M 11.44M 8.66M 7.51M 6.97M
Research & Development
28.68M 24.01M 17.86M 16.19M 12.39M 11.73M 11.55M 11.45M 11.05M 12.3M 13.6M 15.42M 15.65M 13.17M 12.36M 13.8M 13.12M 13.35M 13.32M 10.46M 9.84M 9.91M
Other Expenses
n/a n/a n/a -22K -22K -22K -22K n/a n/a n/a n/a n/a n/a -2.21M -5.34M -9.14M -11.52M -11.75M -11.72M -10.46M -9.84M -14.12M
Operating Expenses
46.09M 39.88M 32.81M 29.81M 25.62M 25.05M 25.18M 25M 23.86M 24.7M 25.5M 27.15M 27.47M 21.3M 19.22M 19.28M 15.82M 16.23M 13.04M 8.66M 7.51M 2.76M
Interest Expense
6K 6K 6K 5K n/a n/a n/a 7K 11K 13K 13K 12K 16K 14K 15K 15K 13K 13K 12K 73K 302K 524K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
46.09M 39.88M 32.81M 29.83M 25.64M 25.07M 25.2M 25M 23.86M 24.7M 25.5M 27.15M 27.47M 23.5M 24.56M 29.32M 28.24M 28.88M 25.67M 19.12M 17.35M 16.88M
Income Tax Expense
n/a n/a n/a n/a n/a n/a 100K 100K 100K 100K n/a n/a n/a n/a 200K 200K 300K 300K 115K 115K 15K 15K
Shares Outstanding (Basic)
12.41M 8.42M 8.42M 8.06M 6.59M 6.58M 5.77M 5.46M 6.4M 4.14M 2.08M 2.04M 2.04M 2.04M 2.04M 2.01M 1.76M 1.67M 1.67M 1.53M 1.47M 1.41M
Shares Outstanding (Diluted)
12.41M 8.42M 8.42M 8.06M 6.59M 6.58M 5.77M 5.46M 6.4M 4.14M 2.08M 2.04M 2.04M 2.04M 2.04M 2.01M 1.76M 1.67M 1.67M 1.53M 1.47M 1.41M
EPS (Basic)
-0.11 0.02 -3.62 -3.40 -3.20 -3.09 -3.49 -4.53 -6.92 -8.87 -9.91 -10.57 -9.42 -8.45 -10.43 -12.32 -10.91 -9.53 -8.34 -3.18 -3.74 -6.12
EPS (Diluted)
-0.11 0.02 -3.62 -3.40 -3.20 -3.09 -3.49 -4.53 -6.92 -8.87 -9.91 -10.57 -9.42 -8.45 -10.43 -12.32 -10.91 -9.53 -8.34 -3.18 -3.74 -6.12
EBITDA
-6.39M -715K -31.06M -28.34M -23.82M -22.83M -22.52M -22.51M -25.21M -26.01M -25.86M -27.51M -24.44M -21.32M -24.77M -28.19M -24.09M -20.84M -15.9M -4.56M -6.03M -9.3M
EBIT
-6.4M -723K -31.07M -28.37M -23.87M -22.9M -22.61M -22.6M -25.3M -26.1M -25.95M -27.6M -24.53M -21.41M -24.86M -28.28M -24.18M -20.93M -15.99M -4.65M -6.12M -9.39M
Depreciation & Amortization
7K 8K 16K 36K 56K 76K 89K 90K 90K 90K 90K 90K 92K 91K 92K 91K 89K 89K 89K 89K 90K 90K

© 2026 bestshares.com. All rights reserved.